Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lymphoma,2015,NCI,5R37CA076584-17,,F-box proteins: deregulated cell cycle control and proteolysis in cancer,"PAGANO, MICHELE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$446,546"
Lymphoma,2015,NHLBI,5R01HL116217-03,,Engraftment and in vivo selection of HIV-protected stem cells,"KIEM, HANS-PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$792,237"
Lymphoma,2015,NCI,1K22CA184308-01,,Dissecting Genetic and Epigenetic variation in the Cancer Regulome,"HODGES, EMILY",VANDERBILT UNIVERSITY,TN,"$157,854"
Lymphoma,2015,NCI,1K22CA188106-01,,Characterization of replication-mediated DNA damage in B lymphocytes,"BARLOW, JACQUELINE",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$162,000"
Lymphoma,2015,NCI,5R01CA085180-14,,Epstein-Barr Virus LMP1-Mediated Oncogenecity,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$701,405"
Lymphoma,2015,NIAID,5R01AI105114-02,,Viral Interface with an Interferon-Induced Gene,"REICH, NANCY",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$463,541"
Lymphoma,2015,NCI,5R01CA164178-03,,A novel NKG2D-specific BiTE cancer immunotherapy,"SENTMAN, CHARLES",DARTMOUTH COLLEGE,NH,"$336,150"
Lymphoma,2015,NCI,5R01CA166450-03,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2015,NCI,5R01CA168482-03,,HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2015,NCI,5R01CA172492-03,,Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma,"PASQUALUCCI, LAURA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Lymphoma,2015,NCI,5R21CA175821-02,,The role of b-catenin/Tcf-1 signaling in T-cell leukemia/lymphoma,"GOUNARI, FOTINI",UNIVERSITY OF CHICAGO,IL,"$201,346"
Lymphoma,2015,NCI,5R01CA172582-03,,Alpha Radioimmunotherapy for Lymphoma Treatment,"SANDMAIER, BRENDA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$634,846"
Lymphoma,2015,NCI,5R01CA148950-05,,Regulation of Myc-Mediated Tumorigenesis,"EISCHEN, CHRISTINE",VANDERBILT UNIVERSITY,TN,"$323,421"
Lymphoma,2015,NCI,5R03CA175426-02,,"Function on Non-Coding RNA, MALAT1, in B-cell development and Lymphoma","RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$77,000"
Lymphoma,2015,NCI,5R21CA175912-02,,Cellular and Biologic Origins of CLL,"DAVIS, RANDALL",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$159,863"
Lymphoma,2015,NIAID,5R01AI106393-03,,BH3-only protein targeting by HHV-8,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$405,000"
Lymphoma,2015,NIAID,5R21AI105340-02,,A recombinant virus approach for gamma herpesvirus oncogenesis,"FENG, PINGHUI",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$205,885"
Lymphoma,2015,NCI,5P30CA016086-39,8689,Virology,"RAAB-TRAUB, NANCY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$163,821"
Lymphoma,2015,NCI,5P30CA016086-39,8690,Virology,"RAAB-TRAUB, NANCY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$173,150"
Lymphoma,2015,NCI,5R01CA117830-10,,Regulation of KSHV Latency,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$318,853"
Lymphoma,2015,NCI,5R03CA182984-02,,Development of Integrated Analysis Methods and Applications to TCGA data,"MA, SHUANGGE",YALE UNIVERSITY,CT,"$83,250"
Lymphoma,2015,NCI,5R01CA182461-02,,Defining the impact of clonal evolution on chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$362,378"
Lymphoma,2015,NCI,5R01CA165206-04,,CD19 Directed CAR Therapy,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$504,482"
Lymphoma,2015,NIEHS,5R01ES010807-15,,Molecular Mechanisms of Complex Mixture Toxicity,"PUGA, ALVARO",UNIVERSITY OF CINCINNATI,OH,"$452,014"
Lymphoma,2015,NCI,5R21CA183445-02,,GSK3 inhibition as an adjuvant therapy for Burkitt's lymphoma,"THOMAS-TIKHONENKO, ANDREI",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$255,780"
Lymphoma,2015,NCI,5R01CA183444-02,,Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$527,877"
Lymphoma,2015,NCI,5R01CA134674-06,,GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA,"CAMP, NICOLA",UNIVERSITY OF UTAH,UT,"$525,551"
Lymphoma,2015,NCI,5R01CA158073-05,,The Role of ATM in Suppression of Lymphomas,"ZHA, SHAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Lymphoma,2015,NCI,5R01CA119917-08,,Studying the role of KSHV-encoded miRNAs,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$301,913"
Lymphoma,2015,NCI,5P30CA006516-50,6047,Lymphoma and Myeloma,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$93,249"
Lymphoma,2015,NCI,5R01CA166144-04,,Development of Therapeutic CD59 inhibitor for treating B-cell malignancies,"QIN, XUEBIN",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$327,872"
Lymphoma,2015,NCI,5R01CA154228-05,,Targeting vFLIP for the treatment of KSHV-associated malignancies,"CESARMAN, ETHEL",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$350,675"
Lymphoma,2015,NCI,5R01CA164605-04,,Hdac3 as a therapeutic target in BCL6-dependent lymphoma,"HIEBERT, SCOTT",VANDERBILT UNIVERSITY,TN,"$403,135"
Lymphoma,2015,NCI,5R01CA165469-03,,Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,"BONDADA, SUBBARAO",UNIVERSITY OF KENTUCKY,KY,"$381,420"
Lymphoma,2015,NIAID,5R01AI018757-33,,Host Immunity to EBV Infection in Vitro and in Vivo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$412,500"
Lymphoma,2015,NCI,5F31CA183569-02,,The Role of ATF4 in Promoting c-Myc Induced Lymphomagenesis,"TAMEIRE, FEVEN",UNIVERSITY OF PENNSYLVANIA,PA,"$43,120"
Lymphoma,2015,NHLBI,5R01HL116452-03,,The role of the SF3B1 splicing factor in chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$428,101"
Lymphoma,2015,NCI,1P01CA190193-01,8720,Project 1: Direct & Repeated pO2 Measurements for Cancer using EPR with Carbon Pa,"KUPPUSAMY, PERIANNAN",DARTMOUTH COLLEGE,NH,"$476,931"
Lymphoma,2015,NCI,5R00CA166181-03,,Specificity of the Ubiquitin System in Lymphoid Malignancies,"BUSINO, LUCA",UNIVERSITY OF PENNSYLVANIA,PA,"$242,678"
Lymphoma,2015,NIAID,5R21AI107237-02,,IRF4 Functions as a Negative Regulator of Notch Signaling in the Development of M,"LU, RUNQING",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$188,125"
Lymphoma,2015,NCI,1R01CA190384-01,,The genomic pathogenesis of Follicular Lymphoma,"MALEK, SAMI",UNIVERSITY OF MICHIGAN,MI,"$556,205"
Lymphoma,2015,NIAID,1R01AI114556-01,,"Targeting Fnip1 to disrupt B cell development, metabolism, and transformation","IRITANI, BRIAN",UNIVERSITY OF WASHINGTON,WA,"$396,614"
Lymphoma,2015,NCI,1R01CA192267-01,,Monitoring disease progression in follicular lymphoma with next-gen sequencing,"CARLSON, CHRISTOPHER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$513,853"
Lymphoma,2015,NCI,1R01CA190964-01,,Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia,"VAN ETTEN, RICHARD",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$557,731"
Lymphoma,2015,NIAID,5R37AI037526-21,,Class Switch Recombination in B Lymphocytes,"NUSSENZWEIG, MICHEL",ROCKEFELLER UNIVERSITY,NY,"$423,750"
Lymphoma,2015,NCI,5R01CA091791-13,,Reactivation of Kaposi's Sarcoma-Associated Herpesvirus,"SUN, REN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$284,547"
Lymphoma,2015,NIGMS,1K99GM112877-01,,Understanding Epstein Barr virus oncogenicity through non-coding RNA structure,"MOSS, WALTER",YALE UNIVERSITY,CT,"$90,000"
Lymphoma,2015,NCI,1K99CA190803-01,,The role of PRDM1 in epigenetic regulation and tumor suppression,"CARLSON, SCOTT",STANFORD UNIVERSITY,CA,"$112,614"
Lymphoma,2015,NCI,5UM1CA173642-03,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$2,539,856"
Lymphoma,2015,NCI,5U01CA183012-02,,Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient,"ZAIA, JOHN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$496,292"
Lymphoma,2015,NIAID,5R01AI110328-02,,Viral Long Noncoding RNA Functions in Epstein-Barr Virus Infection,"SAMPLE, JEFFERY",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$371,712"
Lymphoma,2015,NCI,5R01CA180813-02,,Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs,"GOTTWEIN, EVA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,588"
Lymphoma,2015,NIAID,5R01AI058057-11,,Function of the Gamma HV68 M2 Antigen,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$385,800"
Lymphoma,2015,NIAID,5R01AI106676-02,,Epstein Barr virus antisense transcription,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$376,250"
Lymphoma,2015,NIAID,5R01AI109644-02,,Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di,"SUN, ZUOMING",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$420,000"
Lymphoma,2015,NCI,5R00CA154889-05,,Mechanisms of subtelomere recombination in telomerase deficient tumors,"MORRISH, TAMMY",UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS,OH,"$234,060"
Lymphoma,2015,NIEHS,5R01ES021832-03,,Endocrine disrupter modulation of SXR in development and lymphomagenesis,"BLUMBERG, BRUCE",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$347,625"
Lymphoma,2015,NCI,1R21CA184707-01A1,,Genomic instability mediated via differential DNA repair mechanisms in B cells,"WANG, JING",UNIVERSITY OF COLORADO DENVER,CO,"$168,789"
Lymphoma,2015,NCI,1R21CA191726-01,,Therapeutic targeting of the B-cell lymphoma associated mutation MYD88-L265P,"SNYDER, GREG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$215,284"
Lymphoma,2015,NCI,5K23CA154874-03,,Optimization of adoptive immunotherapy with autologous CD20-specific T cells,"TILL, BRIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$171,720"
Lymphoma,2015,NCI,5R01CA088763-14,,LANA and Cellular Gene Expression,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$230,935"
Lymphoma,2015,NCI,1R01CA184187-01A1,,DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations,"ZHA, SHAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Lymphoma,2015,NIAID,2R01AI072194-06A1,,Elucidation of Immunoglobulin Class Switch Recombination,"CHAUDHURI, JAYANTA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$438,958"
Lymphoma,2015,NIAID,5U01AI104342-03,,Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children,"ESQUIVEL, CARLOS",STANFORD UNIVERSITY,CA,"$1,363,549"
Lymphoma,2015,NCI,5R00CA151827-04,,Role of Replication Stress during Myc-dependent Lymphomagenesis,"DOMINGUEZ-SOLA, DAVID",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$244,070"
Lymphoma,2015,NCI,5R01CA170023-03,,Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$392,517"
Lymphoma,2015,NIAID,5R01AI101046-04,,Intercellular communication in Epstein Barr virus reactivation,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$376,250"
Lymphoma,2015,NCI,5P50CA094056-15,7927,Imaging NFkB Activation in HTLV Lymphoma,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$112,629"
Lymphoma,2015,NCI,5R01CA155226-05,,Targeting the heat shock response for the therapy of DLBCL,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$492,767"
Lymphoma,2015,NIAID,1R21AI111125-01A1,,Role of PRMT5 in HTLV-1 transformation and disease,"GREEN, PATRICK",OHIO STATE UNIVERSITY,OH,"$192,500"
Lymphoma,2015,NIDDK,1K08DK100739-01A1,,The Intraepithelial T cell Response in Celiac Disease,"HAN, ARNOLD",STANFORD UNIVERSITY,CA,"$143,963"
Lymphoma,2015,NCI,1R03CA186223-01A1,,Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?,"SALZ, TALYA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$87,950"
Lymphoma,2015,NCI,5P30CA016520-39,5516,Tumor Virology Program,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$120,816"
Lymphoma,2015,NCI,5P30CA016520-39,5520,Melanoma and Cutaneous Malignancies Program,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$121,032"
Lymphoma,2015,NCI,5P30CA016520-39,5521,Hematologic Malignancies Program,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$141,103"
Lymphoma,2015,NIAID,5R01AI076183-13,,Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$507,585"
Lymphoma,2015,NCI,5R01CA157660-04,,The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis,"KLEIN, ULF",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$331,240"
Lymphoma,2015,NCI,1R01CA172724-01A1,,Novel Strategies to Target Leukemia-Stromal Interactions,"HUANG, PENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Lymphoma,2015,NIAID,5R21AI111129-02,,Uracil DNA glycosylases in herpesvirus pathogenesis and DNA mutation,"KRUG, LAURIE",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$236,071"
Lymphoma,2015,NCI,5R01CA063417-15,,PROLIFERATIVE EFFECTS OF HTLV-1,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$158,641"
Lymphoma,2015,NCI,5R01CA070723-18,,Genetic Analysis of EBV's Immortalizing Genes,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN-MADISON,WI,"$291,588"
Lymphoma,2015,NCI,5R01CA174462-03,,New Models and Treatments for AIDS-related Lymphoma,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$416,873"
Lymphoma,2015,NCI,5R01CA124332-09,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$303,864"
Lymphoma,2015,NCI,5R01CA162411-03,,Novel monocyte effector function in CLL immune therapy,"TRIDANDAPANI, SUSHEELA",OHIO STATE UNIVERSITY,OH,"$319,550"
Lymphoma,2015,NCI,5R01CA164152-04,,Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Lymphoma,2015,NCI,5R01CA166219-04,,Molecular epidemiology of non-Hodgkin lymphoma prognosis and prevention,"WANG, SOPHIA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$579,375"
Lymphoma,2015,NCI,5R01CA174794-03,,Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation,"KRULL, KEVIN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$642,665"
Lymphoma,2015,NCI,5R01CA177319-03,,The Role of NOTCH1 in the Pathogenesis of CLL.,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$358,315"
Lymphoma,2015,NCI,5R01CA137488-20,,Two Compartment Models to Improve Brain Tumor Therapy,"NEUWELT, EDWARD",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$477,492"
Lymphoma,2015,NCI,5R01CA158323-04,,Studies of Lymphoma Suppression and DNA Repair,"DU, CHUNYING",UNIVERSITY OF CINCINNATI,OH,"$325,775"
Lymphoma,2015,NCI,5F31CA171532-03,,Identifying Regulators of Oncogenic CARD11 in Diffuse Large B Cell Lymphoma,"MACKIE, DEMAURI",JOHNS HOPKINS UNIVERSITY,MD,"$43,120"
Lymphoma,2015,NCI,5R03CA175872-02,,Targeting the tumor microenvironment in B-cell malignancies,"ELSAWA, SHERINE",NORTHERN ILLINOIS UNIVERSITY,IL,"$73,500"
Lymphoma,2015,NCI,5R01CA113809-09,,Role of Missing Metastasis Gene in tumor progression,"ZHAN, STEVEN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$264,562"
Lymphoma,2015,NCI,5R01CA155010-05,,Personal tumor neoantigens for immunity against chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$363,125"
Lymphoma,2015,NCI,5F31CA171596-02,,STAT3: At the Crossroads of Inflammation and Cancer,"FOGLI, LAURA",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$25,590"
Lymphoma,2015,NIAID,5R21AI109020-02,,Folliculin Interacting Proteins in Lymphocyte Development and Autoimmunity,"IRITANI, BRIAN",UNIVERSITY OF WASHINGTON,WA,"$231,750"
Lymphoma,2015,NCI,5R01CA166741-04,,Anticancer drug-induced BH3-only protein.Bak interactions,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$321,459"
Lymphoma,2015,NCI,5R01CA177600-03,,Regulation of CARD11 signaling in normal and dysregulated lymphocyte development,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Lymphoma,2015,NCI,5P30CA086862-15,8601,Cancer Immunology and Immunotherapy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$49,607"
Lymphoma,2015,NCI,5P30CA086862-15,8684,Protocol Specific Research Support,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$52,261"
Lymphoma,2015,NCI,5R03CA179558-02,,"Autoimmune Conditions, Genetic Variations, and Lymphoma Etiology","WANG, SOPHIA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$84,000"
Lymphoma,2015,NCI,5R01CA151748-05,,Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$486,627"
Lymphoma,2015,NCI,5F31CA177092-03,,Cyclin D3 and DNA double strand breaks: genome stability and lymphomagenesis,"DEMICCO, AMY",UNIVERSITY OF PENNSYLVANIA,PA,"$10,495"
Lymphoma,2015,NCI,5F30CA174232-03,,Combination therapies with interleukin-21 in chronic lymphocytic leukemia,"BROWNING, REBEKAH",OHIO STATE UNIVERSITY,OH,"$37,152"
Lymphoma,2015,NCI,5R01CA166325-04,,Mechanisms promoting translocations and mature B cell lymphomas,"WANG, JING",UNIVERSITY OF COLORADO DENVER,CO,"$322,806"
Lymphoma,2015,NCI,5R01CA184384-02,,Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$528,101"
Lymphoma,2015,NCI,1R43CA192540-01,,"Preclinical Development of BILT, a Next-Generation Immunotoxin Therapy for CTCL","GUYRE, PAUL","CELDARA MEDICAL, LLC",NH,"$299,052"
Lymphoma,2015,NCI,1F30CA183263-01A1,,Multifunctional polymeric carriers for the intracellular delivery of protein cancer therapeutics,"KERN, HANNA",UNIVERSITY OF WASHINGTON,WA,"$37,171"
Lymphoma,2015,NCI,1R44CA192576-01,,A Phase I Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy,"BASILE, LENA","NEUMEDICINES, INC.",CA,"$1,088,333"
Lymphoma,2015,NCI,5R01CA177292-03,,Targeted Therapy for Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$536,708"
Lymphoma,2015,NCI,5P01CA174653-02,6841,The Role of CTIP in Lymphocyte Development and Lymphomagenesis,"ZHA, SHAN",COLUMBIA UNIVERSITY,NY,"$364,328"
Lymphoma,2015,NCI,5P01CA174653-02,6845,Pathology,"BHAGAT, GOVIND",COLUMBIA UNIVERSITY,NY,"$188,901"
Lymphoma,2015,NCI,1F31CA192835-01,,Intratumoral Heterogeneity and Tumor Evolution in Lymphoma,"KASTENHUBER, EDWARD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$43,120"
Lymphoma,2015,NCI,1F31CA183551-01A1,,Mechanisms and Function of Suppressed RAG Expression by DNA Double Strand Breaks,"FISHER, MEGAN",UNIVERSITY OF PENNSYLVANIA,PA,"$43,120"
Lymphoma,2015,NIGMS,1R01GM111741-01A1,,High-throughput informatics for antibodies,"MACCARTHY, THOMAS",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$296,508"
Lymphoma,2015,NIAMS,1F32AR067668-01,,Molecular Alterations Characterizing Disease Progression of Cutaneous T Cell Lymphoma,"ELCO, CHRISTOPHER",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$64,226"
Lymphoma,2015,NCI,1F30CA183520-01A1,,Targeting CD37 and elucidating its role in B-cell malignancy,"BECKWITH, KYLE",OHIO STATE UNIVERSITY,OH,"$37,475"
Lymphoma,2015,NCI,1R01CA187299-01A1,,Epigenetic Gene Regulation by JAK1 Kinase in Diffuse Large B-Cell Lymphoma,"RUI, LIXIN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$349,988"
Lymphoma,2015,NCI,5R01CA129037-08,,Replicative Senescence as a Tumor Suppressive Mechanism,"CHANG, SANDY",YALE UNIVERSITY,CT,"$306,860"
Lymphoma,2015,NCI,5R01CA160256-04,,Temporal and Spatial Control of V(D)J Recombination,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Lymphoma,2015,NIGMS,5R01GM103843-03,,Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes,"YIN, HANG",UNIVERSITY OF COLORADO,CO,"$362,950"
Lymphoma,2015,NCI,5R01CA160300-05,,Cellular Response to Short Telomeres in B-Cell Lymphoma,"GREIDER, CAROL",JOHNS HOPKINS UNIVERSITY,MD,"$519,945"
Lymphoma,2015,NCI,5R21CA184694-02,,Targeted Therapies in CNS Lymphomas,"RUBENSTEIN, JAMES","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$206,680"
Lymphoma,2015,NCI,5R01CA182947-02,,Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells,"FARAG, SHERIF",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$325,817"
Lymphoma,2015,NCI,5R01CA167093-05,,Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis,"CLEVELAND, JOHN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$349,638"
Lymphoma,2015,NCI,5R01CA076167-12,,Genetic Analysis of Myeloproliferative Disease,"COWELL, JOHN",GEORGIA REGENTS UNIVERSITY,GA,"$307,125"
Lymphoma,2015,NCI,5R01CA151351-05,,Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy,"GALARDY, PAUL",MAYO CLINIC ROCHESTER,MN,"$327,228"
Lymphoma,2015,NCI,1R21CA192854-01,,The coding genome of HIV-associated plasmablastic lymphomas in South Africa,"WILLEM, PASCALE","WITS HEALTH CONSORTIUM (PTY), LTD",SO AFR,"$108,800"
Lymphoma,2015,NCI,5R01CA151899-05,,Communication Skills Intervention to Promote Transition into Survivorship,"HORWITZ, STEVEN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$587,964"
Lymphoma,2015,NCI,5R21CA185508-02,,(PQA2) Impact of obesity on endogenous mutational hotspots,"VASQUEZ, KAREN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$168,019"
Lymphoma,2015,NCI,5R01CA090571-14,,"CRTC2 in Cellular Development, Function, and Neoplasia","TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$273,031"
Lymphoma,2015,NCI,5R01CA162964-05,,Antibody-interferon fusion proteins for treatment of B-cell malignancies,"MORRISON, SHERIE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2015,NCI,5R01CA164641-03,,Natural Killer Cell Regulation by PRDM1 and IRF4/8,"WRIGHT, KENNETH",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$314,674"
Lymphoma,2015,NIAID,5R21AI105751-02,,"Chronic Fatigue Syndrome, Immune Dysregulation, and Non-Hodgkin's Lymphoma","MOSLEHI, ROXANA",STATE UNIVERSITY OF NEW YORK AT ALBANY,NY,"$153,000"
Lymphoma,2015,NCI,5R01CA159296-04,,Novel Immunotherapies for Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$316,438"
Lymphoma,2015,NCI,5R03CA184127-02,,A Novel Multimodality Immune Based Platform in Advanced Mycosis Fungoides,"DIEFENBACH, CATHERINE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$84,750"
Lymphoma,2015,NIGMS,5R01GM110052-02,,Functional roles of lipids in early B cell receptor signaling.,"VEATCH, SARAH",UNIVERSITY OF MICHIGAN,MI,"$288,618"
Lymphoma,2015,NCI,5R01CA183876-02,,Towards The Chemotherapy-Free Treatment of Follicular Lymphoma,"WENDEL, HANS-GUIDO",SLOAN-KETTERING INST CAN RESEARCH,NY,"$475,801"
Lymphoma,2015,NCI,5P01CA022443-38,6859,Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,"MERTZ, JANET",UNIVERSITY OF WISCONSIN-MADISON,WI,"$347,683"
Lymphoma,2015,NCI,5P01CA022443-38,6863,miRNA and v-Cdks: Independent Drivers OF EBV and HCMV Replication and Oncogenesi,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$395,189"
Lymphoma,2015,NCI,5R01CA156674-05,,A Fourth Outcome: DNA Damage and the Differentiation of B Cells,"TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$314,884"
Lymphoma,2015,NCI,5F30CA168358-04,,The interaction of Burkitt's lymphoma cofactors EBV and Plasmodium,"WOHLFORD, ERIC",UPSTATE MEDICAL UNIVERSITY,NY,"$47,591"
Lymphoma,2015,NCI,5R21CA185236-02,,(PQD5)Biomaterials-based Adaptive Tumor Microenvironments for In Vitro Drug Scree,"SINGH, ANKUR",CORNELL UNIVERSITY,NY,"$215,652"
Lymphoma,2015,NIDCR,1K99DE024969-01,,Factors Influencing KSHV Infection and Spread within the Oral Cavity,"TOTONCHY, JENNIFER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$123,050"
Lymphoma,2015,NIAID,1R01AI108407-01A1,,Role of MHV68 miRNAs in latencyand pathogenesis,"TIBBETTS, SCOTT",UNIVERSITY OF FLORIDA,FL,"$364,230"
Lymphoma,2015,NCI,5R01CA096500-13,,Role of KSHV viral proteins in signaling and pathogenesis,"DAMANIA, BLOSSOM",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$281,108"
Lymphoma,2015,NCI,5R01CA106258-11,,HTLV-I Tax induces DNA breaks and inhibits HR repair through activation of NF-kB,"NICOT, CHRISTOPHE",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$224,009"
Lymphoma,2015,NCI,5R01CA151533-05,,Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma,"AMIN, HESHAM",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$327,850"
Lymphoma,2015,NCI,5U54CA155496-05,5936,Social Determinants in the Link between Obesity and Cancer,"HOVMAND, PETER",WASHINGTON UNIVERSITY,MO,"$183,604"
Lymphoma,2015,NCI,5R01CA141070-05,,Role of the mitochondrial RNA polymerase POLRMT in MYC function,"MCMAHON, STEVEN",THOMAS JEFFERSON UNIVERSITY,PA,"$289,463"
Lymphoma,2015,NIGMS,5R01GM107058-03,,Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy,"WANG, HONGBING",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$291,650"
Lymphoma,2015,NCI,7R01CA185372-02,,(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies,"RICHARDS, KRISTY",CORNELL UNIVERSITY,NY,"$335,822"
Lymphoma,2015,NCI,5P01CA049605-26,5891,Immune Regulation in HCT,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$1,151,707"
Lymphoma,2015,NCI,5P01CA049605-26,5892,Auto-lmmunotransplantation for Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$199,530"
Lymphoma,2015,NCI,5P01CA049605-26,5893,Memory CDS T Cells for GVL,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$150,528"
Lymphoma,2015,NCI,5P01CA049605-26,5894,Improving Graft-versus-Leukemia Alloimmunity against CLL,"MIKLOS, DAVID",STANFORD UNIVERSITY,CA,"$135,776"
Lymphoma,2015,NCI,5P01CA049605-26,5897,Administration and Clinical Trial Coordination,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$258,742"
Lymphoma,2015,NCI,5P01CA049605-26,5898,Biostatistics and Data Management,"LAVORI, PHILIP",STANFORD UNIVERSITY,CA,"$186,995"
Lymphoma,2015,NCI,5P01CA049605-26,5899,Molecular Diagnostics,"ZEHNDER, JAMES",STANFORD UNIVERSITY,CA,"$239,457"
Lymphoma,2015,NCI,5P01CA049605-26,5900,Cell Processing and Sample Distribution Laboratory,"LOWSKY, ROBERT",STANFORD UNIVERSITY,CA,"$377,265"
Lymphoma,2015,NCI,5U01CA174844-03,,A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia,"RADER, CHRISTOPH",SCRIPPS FLORIDA,FL,"$487,154"
Lymphoma,2015,NCI,5R01CA093606-13,,Regulation of EBV Latency by EBNA1,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$321,273"
Lymphoma,2015,NCI,5R01CA117794-10,,Inhibitors of the Epstein-Barr Virus Entry Machinery,"JARDETZKY, THEODORE",STANFORD UNIVERSITY,CA,"$331,208"
Lymphoma,2015,NCI,5R01CA178453-02,,Role of MEF2B mutations in lymphomagenesis,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$443,555"
Lymphoma,2015,NCI,5R01CA160556-05,,Escape from gammaherpesvirus-induced mRNA destruction,"GLAUNSINGER, BRITT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$309,252"
Lymphoma,2015,NIAID,5R01AI067968-09,,Role and mechanism of action of gamma herpesvirus microRNAs,"CULLEN, BRYAN",DUKE UNIVERSITY,NC,"$392,500"
Lymphoma,2015,NCI,5R01CA085563-13,,"ROS, Redox Regulation and Novel Targets for Cancer Therapy","HUANG, PENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$233,579"
Lymphoma,2015,NCI,5R01CA182905-02,,Protein-coding and non-coding RNA biomarkers for early detection of CLL,"CALIN, GEORGE",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$677,471"
Lymphoma,2015,NCI,5R01CA047006-28,,Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$565,231"
Lymphoma,2015,NCI,5R01CA120185-09,,c-Myc-regulated microRNAs in normal and pathologic cellular physiology,"MENDELL, JOSHUA",UT SOUTHWESTERN MEDICAL CENTER,TX,"$293,037"
Lymphoma,2015,NCI,5R01CA170006-03,,Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme,"GHOSH, ASISH",MAYO CLINIC ROCHESTER,MN,"$327,744"
Lymphoma,2015,NCI,5R01CA168558-04,,Cyclin requirements in gammaherpesvirus infection and disease,"VAN DYK, LINDA",UNIVERSITY OF COLORADO DENVER,CO,"$309,073"
Lymphoma,2015,NIDCD,5R01DC014367-02,,CRCNS: Dynamical mechanisms of oscillation transitions in the olfactory system,"KAY, LESLIE",UNIVERSITY OF CHICAGO,IL,"$313,407"
Lymphoma,2015,NIAID,5R21AI113033-02,,Novel regulatory regions within the immunoglobulin kappa locus,"FEENEY, ANN",SCRIPPS RESEARCH INSTITUTE,CA,"$236,875"
Lymphoma,2015,NIAID,1R01AI114557-01A1,,Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$434,048"
Lymphoma,2015,NCI,5R21CA185833-02,,Epigenetic regulation of T-cell dysfunction in chronic lymphocytic leukemia,"SHI, HUIDONG",GEORGIA REGENTS UNIVERSITY,GA,"$165,209"
Lymphoma,2015,NCI,1R01CA193300-01,,Viral Non-Coding RNAs and Cell Transformation,"STEITZ, JOAN",YALE UNIVERSITY,CT,"$271,516"
Lymphoma,2015,NCI,5R01CA184922-02,,(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$553,684"
Lymphoma,2015,NIAID,5R44AI096588-04,,Development of a Small Molecule Inhibitor for EBV Latent Infection,"VAN DEN HEUVEL, PIETER","VIRONIKA, LLC",PA,"$750,000"
Lymphoma,2015,NCI,1R01CA193541-01,,Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia,"SHANAFELT, TAIT",MAYO CLINIC ROCHESTER,MN,"$542,925"
Lymphoma,2015,NCI,5R01CA154674-05,,Cotranslational Functions of MTOR,"JACINTO, ESTELA",RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,NJ,"$328,265"
Lymphoma,2015,NHLBI,5U10HL069233-15,,Nebraska/Kansas Blood and Marrow Transplant Research Network,"VOSE, JULIE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$154,372"
Lymphoma,2015,NHLBI,5U10HL108945-05,,Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$160,218"
Lymphoma,2015,NHLBI,5U10HL109322-05,,The Ohio State Blood and Marrow Transplant Reseach Consortium,"DEVINE, STEVEN",OHIO STATE UNIVERSITY,OH,"$151,206"
Lymphoma,2015,NCI,1K22CA193674-01,,Lymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance,"LIN, YI",MAYO CLINIC ROCHESTER,MN,"$192,485"
Lymphoma,2015,NCI,1R01CA193624-01,,Development of a Novel Inducer for EBV Lytic Therapy,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$591,954"
Lymphoma,2015,NCI,5R01CA163910-04,,TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM,"HU, CHIH-CHI",WISTAR INSTITUTE,PA,"$393,518"
Lymphoma,2015,NCI,5R01CA164679-04,,HVEM-BTLA Pathway in Lymphoma,"WARE, CARL",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$404,625"
Lymphoma,2015,NCI,5R01CA129974-09,,Probing mitochondria and personalizing leukemia therapy with BH3 profiling,"LETAI, ANTHONY",DANA-FARBER CANCER INST,MA,"$315,153"
Lymphoma,2015,NCI,1R01CA193655-01,,Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$508,898"
Lymphoma,2015,NIAID,1R21AI112602-01A1,,Chromosome fragility and translocations in lymphocytes,"ROBBIANI, DAVIDE",ROCKEFELLER UNIVERSITY,NY,"$211,875"
Lymphoma,2015,NCI,1R01CA194547-01,,The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma,"ELEMENTO, OLIVIER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$530,098"
Lymphoma,2015,NCI,5R01CA180150-03,,(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition,"PETROSKI, MATTHEW",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$558,328"
Lymphoma,2015,NCI,5R01CA130995-08,,"Replication Licensing in Genome Stability, Cancer and Aging","PRUITT, STEVEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$324,743"
Lymphoma,2015,RMAP,5R01CA174385-04,,Quantitative single-cell biomarkers of T-cells to optimize tumor immunotherapy,"VARADARAJAN, NAVIN",UNIVERSITY OF HOUSTON,TX,"$455,093"
Lymphoma,2015,NIGMS,5SC3GM103713-03,,Characterization of novel compounds with anti-lymphoma activity,"AGUILERA, RENATO",UNIVERSITY OF TEXAS EL PASO,TX,"$113,250"
Lymphoma,2015,NCI,5R01CA164346-04,,CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF,"YOU, M. JAMES",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$300,001"
Lymphoma,2015,NCI,5P01CA174439-03,8216,Role of LANA-RBP-jk During Early KSHV Infection,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$134,054"
Lymphoma,2015,NCI,5P01CA174439-03,8218,Chromatin Regulation of KSHV Primary Infection,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$155,185"
Lymphoma,2015,NCI,1U01CA194389-01,,Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma,"ALIZADEH, ARASH",STANFORD UNIVERSITY,CA,"$626,964"
Lymphoma,2015,NCI,5R37CA031845-35,,Synthetic Studies Related to Cancer Research/Treatment,"WENDER, PAUL",STANFORD UNIVERSITY,CA,"$442,838"
Lymphoma,2015,NCI,5R01CA140337-05,,Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$325,775"
Lymphoma,2015,NCI,5R01CA177734-03,,Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas,"FELDMAN, ANDREW",MAYO CLINIC ROCHESTER,MN,"$329,925"
Lymphoma,2015,NCI,5R01CA158402-04,,Molecular mechanisms of B cell malignant transformation,"XIE, PING","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$322,456"
Lymphoma,2015,NCI,5U01CA166905-03,,Identifying non-coding RNAs for early detection and prevention of lung cancer,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$905,221"
Lymphoma,2015,NCI,1R15CA188941-01A1,,Exosome-Dependent Trafficking of Epstein-Barr Virus LMP1,"MECKES, DAVID",FLORIDA STATE UNIVERSITY,FL,"$414,462"
Lymphoma,2015,NIAID,5R21AI109187-02,,B Cell immunodeficiency in BENTA disease,"SNOW, ANDREW",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$184,979"
Lymphoma,2015,NCI,5R01CA165937-04,,Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons,"SILVERBERG, MICHAEL",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$557,051"
Lymphoma,2015,FIC,5K01TW009488-04,,Developing a clinical cohort of histopathologically characterized lymphoma,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$140,175"
Lymphoma,2015,NCI,1R21CA184352-01A1,,Myc-induced pathways in B cell lymphoma initiation and survival,"EISCHEN, CHRISTINE",VANDERBILT UNIVERSITY,TN,"$204,885"
Lymphoma,2015,NCI,5U01CA168426-04,,Systems Biology of Tumor Progression and Drug Resistance,"CALIFANO, ANDREA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$1,232,072"
Lymphoma,2015,NCI,5K08CA172215-03,,The role of GATA-3 in T-cell lymphomas,"WILCOX, RYAN",UNIVERSITY OF MICHIGAN,MI,"$178,618"
Lymphoma,2015,NCI,1R21CA195173-01,,The genetics of hepatosplenic T cell lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$217,108"
Lymphoma,2015,NCI,5F31CA180449-03,,EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell Lymphoma,"O'GRADY, CHRISTINA",TULANE UNIVERSITY OF LOUISIANA,LA,"$41,199"
Lymphoma,2015,NCI,1R21CA185930-01A1,,Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis,"NIKOLOV, DIMITAR",SLOAN-KETTERING INST CAN RESEARCH,NY,"$229,550"
Lymphoma,2015,NCI,5R01CA073507-17,,In Vivo Model of Epstein-Barr Virus Latency,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$372,677"
Lymphoma,2015,NCI,5P50CA097274-14,7186,In Situ Immunization Using Nanoparticles,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$180,123"
Lymphoma,2015,NCI,5P50CA097274-14,7184,The Role of Monocytes in non-Hodgkin Lymphoma,"ANSELL, STEPHEN",UNIVERSITY OF IOWA,IA,"$275,600"
Lymphoma,2015,NCI,5P50CA097274-14,7191,Genetic Epidemiology and Function of Germline and Somatic Variants in DLBCL,"CERHAN, JAMES",UNIVERSITY OF IOWA,IA,"$268,695"
Lymphoma,2015,NCI,5P50CA097274-14,7189,Targeting JAK2 Kinase in Lymphoma,"GUPTA, MAMTA",UNIVERSITY OF IOWA,IA,"$270,847"
Lymphoma,2015,NCI,5P50CA097274-14,7192,Administration,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$131,633"
Lymphoma,2015,NCI,5P50CA097274-14,7194,Biospecimens,"DOGAN, AHMET",UNIVERSITY OF IOWA,IA,"$274,914"
Lymphoma,2015,NCI,5P50CA097274-14,7195,Biostatistics and Bioinformatics,"SMITH, BRIAN",UNIVERSITY OF IOWA,IA,"$192,235"
Lymphoma,2015,NCI,5P50CA097274-14,7197,DEVELOPMENTAL RESEARCH PROGRAM,"LENTZ, STEVEN",UNIVERSITY OF IOWA,IA,"$149,013"
Lymphoma,2015,NCI,5P50CA097274-14,7196,Clinical Research,"HABERMANN, THOMAS",UNIVERSITY OF IOWA,IA,"$297,658"
Lymphoma,2015,NCI,5P50CA097274-14,7198,CAREER DEVELOPMENT PROGRAM,"HOHL, RAYMOND",UNIVERSITY OF IOWA,IA,"$92,642"
Lymphoma,2015,NCI,5R01CA181699-02,,Investigating the roles of lncRNAs in cancer and development,"VENTURA, ANDREA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$427,759"
Lymphoma,2015,NCI,5R01CA149445-05,,A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma,"BIRMANN, BRENDA",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$738,521"
Lymphoma,2015,NCI,5R44CA171469-03,,Molecular Kits and Software for Lymphoid Malignancy Work-ups,"JOHNSON, DAVID","GIGAGEN, INC.",CA,"$256,506"
Lymphoma,2015,NCI,5K05CA160724-05,,Survivorship: Mentoring and Bridging Primary Care and Oncology,"OEFFINGER, KEVIN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$164,278"
Lymphoma,2015,NCI,5R01CA181319-02,,Targeting Stem-Cell Dependent Drug Resistance in Human MCL,"MCCARTY, NAMI",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$313,723"
Lymphoma,2015,NCI,5R21CA181997-02,,Novel role of SAMHD1 as a tumor suppressor in cutaneous T-cell lymphomas,"WU, LI",OHIO STATE UNIVERSITY,OH,"$200,970"
Lymphoma,2015,NCI,1R01CA184137-01A1,,Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy,"ALMASAN, ALEXANDRU",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$362,569"
Lymphoma,2015,NCI,2R01CA142698-06,,Molecular mechanism and relevance of microRNAs in DSB repair pathway choice,"CHOWDHURY, DIPANJAN",DANA-FARBER CANCER INST,MA,"$408,989"
Lymphoma,2015,NCI,1R01CA188286-01A1,,SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA,"PAYTON, JACQUELINE",WASHINGTON UNIVERSITY,MO,"$348,844"
Lymphoma,2015,NCI,1R01CA187415-01A1,,MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma,"LI, YONG",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$445,986"
Lymphoma,2015,NCI,5R01CA187040-02,,Targeting SIRT1 in Mantle Cell Lymphoma,"SETO, EDWARD",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$349,638"
Lymphoma,2015,NCI,5P01CA023766-36,6334,Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to,"O'REILLY, RICHARD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$433,106"
Lymphoma,2015,NCI,5R01CA168477-04,,Immune Modulation by Gammaherpesviruses,"COSCOY, LAURENT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$257,242"
Lymphoma,2015,NCI,5K23CA184279-02,,Molecular determinants of prognosis in limited-stage follicular lymphoma,"LOUISSAINT, ABNER",MASSACHUSETTS GENERAL HOSPITAL,MA,"$140,263"
Lymphoma,2015,NCI,1R01CA184728-01A1,,Targeting Granzyme B to Separate GVH from GVL Responses,"CAO, XUEFANG",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$401,456"
Lymphoma,2015,NCI,1U01CA195568-01,,The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study,"CERHAN, JAMES",MAYO CLINIC ROCHESTER,MN,"$2,405,885"
Lymphoma,2015,NCI,1R01CA188561-01A1,,The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia,"OPAVSKY, RENE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$344,269"
Lymphoma,2015,NCI,5K24CA125440-09,,Clinical and Molecular Studies of Malignant Brain Tumors,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$185,972"
Lymphoma,2015,NCI,5R03CA187854-02,,Impact of Short Inverted Repeats on Genetic Instability at Mutation Hotspots,"VASQUEZ, KAREN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$77,250"
Lymphoma,2015,NCI,1UM1CA182934-01A1,,The NYU Women's Health Study,"ZELENIUCH-JACQUOTTE, ANNE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$788,279"
Lymphoma,2015,NIGMS,5F32GM110998-02,,TISSUE-SPECIFIC MECHANISMS OF EOMESODERMIN-MEDIATED TRANSCRIPTIONAL REGULATION,"SLAGLE, CHRISTOPHER",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$15,973"
Lymphoma,2015,NCI,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$51,621"
Lymphoma,2015,NEI,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$4,539"
Lymphoma,2015,NHLBI,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$36,956"
Lymphoma,2015,NIA,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$2,659"
Lymphoma,2015,NIAID,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$260,112"
Lymphoma,2015,NICHD,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$10,911"
Lymphoma,2015,NIDA,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$26,202"
Lymphoma,2015,NIDDK,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$10,354"
Lymphoma,2015,NIGMS,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$10,354"
Lymphoma,2015,OD,5P30AI027757-28,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$2,835"
Lymphoma,2015,NIDCR,5R21DE024703-02,,Histone variant H3.3 and KSHV LANA in the pathogenesis of oral Kaposi's sarcoma,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$186,016"
Lymphoma,2015,NCI,5R01CA161151-03,,Lig4R278H contribution to HSC and IgH class switching defects and malignancies,"YAN, CATHERINE",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$365,484"
Lymphoma,2015,NCI,5R01CA189806-02,,Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma,"MOORMANN, ANN",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$572,221"
Lymphoma,2015,NIDDK,5F32DK101163-02,,Role of Inflammatory B cells in Liver Fibrosis and Chronic HCV Infection,"THAPA, MANOJ",EMORY UNIVERSITY,GA,"$57,962"
Lymphoma,2015,NCI,5P01CA019014-36,6231,DNA-Protein Interactions in Herpes Viruses,"GRIFFITH, JACK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$270,537"
Lymphoma,2015,NCI,5P01CA019014-36,6234,Cellular Reprogramming by KSHV Latent Genes and miRNAs,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$291,273"
Lymphoma,2015,NCI,5P01CA019014-36,6235,Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2),"RAAB-TRAUB, NANCY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$291,373"
Lymphoma,2015,NCI,5R01CA170386-04,,Novel Pathogen Associated Cancers (PQ12),"GALLOWAY, DENISE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$371,081"
Lymphoma,2015,NIGMS,5R01GM106067-02,,DNA-carbon Assemblies for Multispectral Imaging,"KOOL, ERIC",STANFORD UNIVERSITY,CA,"$320,378"
Lymphoma,2015,NCI,5F30CA189740-02,,Alternative End-Joining in DNA Repair and Chromosomal Translocations,"KUMAR, VIPUL",HARVARD MEDICAL SCHOOL,MA,"$35,829"
Lymphoma,2015,NIAMS,3R01AR054458-07S1,,Monitoring of Stem Cell Engraftment in Arthritic Joints with MR Imaging,"DALDRUP-LINK, HEIKE",STANFORD UNIVERSITY,CA,"$160,500"
Lymphoma,2015,NCI,5R01CA134451-06,,Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma,"GURCAN, METIN",OHIO STATE UNIVERSITY,OH,"$297,785"
Lymphoma,2015,NCI,5K24CA184039-02,,Molecularly Targeted Therapy for Lymphoma,"GOPAL, AJAY",UNIVERSITY OF WASHINGTON,WA,"$174,048"
Lymphoma,2015,NCI,5F32CA180499-02,,Targeting Chronic Lymphocytic Leukemia with DNA Nanoparticles,"RUFF, LAURA",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$56,042"
Lymphoma,2015,NCI,5K23CA160345-05,,Targeting Akt Activation in CLL,"DING, WEI",MAYO CLINIC ROCHESTER,MN,"$167,400"
Lymphoma,2015,NIAMS,5R01AR063962-03,,CTCL immunobiology: lessons from alemtuzumab,"CLARK, RACHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$366,728"
Lymphoma,2015,NCI,5P01CA119070-09,7558,Notch 1 Regulation of T-ALL Genomes,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$292,907"
Lymphoma,2015,NCI,5R01CA161026-05,,Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$425,165"
Lymphoma,2015,NCI,5F31CA186532-02,,The Tumor Suppressive Role of the mir-200 family of microRNAs,"CISSON, JENNIFER",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$36,500"
Lymphoma,2015,NCI,5P30CA046592-27,6464,Hematologic Malignancies/BMT,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$444,089"
Lymphoma,2015,NCI,5K23CA178183-03,,Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia,"WOYACH, JENNIFER",OHIO STATE UNIVERSITY,OH,"$173,232"
Lymphoma,2015,NCI,5P01CA180779-03,8776,Core Director: Hye-Ra-Lee,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$106,572"
Lymphoma,2015,NCI,5R01CA187492-02,,MALT1 Targeted Therapy for B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,713"
Lymphoma,2015,NCI,5F30CA186458-02,,High-resolution analysis of chromatin regulation by the Max network,"KASINATHAN, SIVAKANTHAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$36,782"
Lymphoma,2015,NCI,5R01CA085533-12,,Regulation of p53 acetylation and deacetylation in tumorigenesis,"GU, WEI",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$288,000"
Lymphoma,2015,NCI,5R01CA163217-05,,Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$305,754"
Lymphoma,2015,NIAID,5R21AI108597-02,,Topology of the Hosthogen Genome,"MIRANDA, JJ",J. DAVID GLADSTONE INSTITUTES,CA,"$238,750"
Lymphoma,2015,NCI,5P01CA018029-40,5850,Nonmyeloablative Hematopoietic Cell Allotransplants,"STORB, RAINER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$334,135"
Lymphoma,2015,NCI,5R01CA151319-05,,TOWARD AN UNDERSTANDING OF CLL PROGRESSION,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$34,752"
Lymphoma,2015,NCI,1R01CA179062-01A1,,Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy,"SOTOMAYOR, EDUARDO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$385,444"
Lymphoma,2015,NIAID,5P01AI061093-12,7981,Investigating Blocks to B Cell Memory in CVID,"CUNNINGHAM-RUNDLES, CHARLOTTE",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$319,238"
Lymphoma,2015,NCI,5U01CA157581-05,,Molecular Diagnosis and Prognosis in Aggressive Lymphoma,"RIMSZA, LISA",UNIVERSITY OF ARIZONA,AZ,"$578,423"
Lymphoma,2015,NCI,5R01CA188794-02,,Cell cycle reprogramming for therapeutic targeting of BTK in lymphoma,"CHEN-KIANG, SELINA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,713"
Lymphoma,2015,NCI,5P01CA087497-15,5109,p53 and Chemosensitivity in a Mouse Lymphoma Model,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$414,182"
Lymphoma,2015,NCI,5K99CA183914-02,,A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment,"WAN, LIXIN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$169,668"
Lymphoma,2015,NCI,5R01CA187109-02,,Targeting EZH2 in Germinal Center Derived B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$379,082"
Lymphoma,2015,NCI,1F31CA196153-01,,The Use of Novel Peptide Probes to Study Proteasome Regulation by Src Family Kinases in Diffuse Large B-cell Lymphoma,"CANN, MARISSA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$30,865"
Lymphoma,2015,NCI,1F31CA196209-01,,Examining the Role of Rho Kinase in the Pathogenesis of ABC-DLBCL,"RICKER, EDD",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$43,120"
Lymphoma,2015,NCI,1F30CA196082-01,,Defining the role of mutant XPO1 in chronic lymphocytic leukemia,"HING, ZACHARY",OHIO STATE UNIVERSITY,OH,"$37,855"
Lymphoma,2015,NCI,5F31CA183504-02,,Non-catalytic functions of DNA-PK in DNA repair and tumorigenesis,"CROWE, JENNIFER",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$43,120"
Lymphoma,2015,NCI,5R01CA139083-07,,Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages,"RUBENSTEIN, JAMES","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$370,554"
Lymphoma,2015,NCI,5F31CA165782-04,,"Functional analysis of cIAP2-MATL1, MALT1 and proteolytic targets in B cells","LEE, PEISHAN",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$38,713"
Lymphoma,2015,NCI,5F32CA183381-02,,c-MYC dependent regulation of de novo lipogenesis in B-cell lymphomagenesis,"SCOTT, KRISTEN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$56,042"
Lymphoma,2015,NCI,5P50CA107399-10,5351,CD19-Specific Central Memory T Cell Adoptive Immunotherapy for Non-Hodgkin Lymphoma,"RAUBITSCHEK, ANDREW",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$1,038,189"
Lymphoma,2015,NCI,5P50CA107399-10,5352,Adoptive T Cell Therapy For Non-Hodgkin Lymphoma,"JENSEN, MICHAEL",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$172,534"
Lymphoma,2015,NCI,5P50CA107399-10,5354,Humanized Anti-CD20-IL2 for the Treatment of CD20 Positive Lymphomas,"RAUBITSCHEK, ANDREW",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$224,642"
Lymphoma,2015,NCI,5P50CA107399-10,5353,Therapy-Related Leukemia Following Autologous Transplantation for Lymphoma,"BHATIA, RAVI",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$181,542"
Lymphoma,2015,NCI,5P50CA107399-10,5356,Administrative Core,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$140,112"
Lymphoma,2015,NCI,5P50CA107399-10,5357,Biostatistics and Research Informatics,"NILAND, JOYCE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$41,222"
Lymphoma,2015,NCI,5P50CA107399-10,5358,Tissue Bank for Cellular and Molecular Studies,"WEISS, LAWRENCE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$83,774"
Lymphoma,2015,NCI,5U01CA118444-10,,Genetic Epidemiology of Chronic Lymphocytic Leukemia,"SLAGER, SUSAN",MAYO CLINIC ROCHESTER,MN,"$596,741"
Lymphoma,2015,NCI,5P50CA107399-10,5359,Biologics Manufacturing Core,"COLCHER, DAVID",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$216,379"
Lymphoma,2015,NCI,5P50CA107399-10,5360,Developmental Research Program,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$43,303"
Lymphoma,2015,NCI,5P50CA107399-10,5361,Career Development Program,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$43,303"
Lymphoma,2015,NCI,5R01CA076287-16,,Pretargeted Radioimmunotherapy of CD20+ Lymphomas,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$386,431"
Lymphoma,2015,NCI,5P30CA082103-17,6392,Hematopoietic Malignancies,"MCCORMICK, FRANK","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,$154
Lymphoma,2015,NCI,5R21CA188824-02,,Plasma and serum biomarkers for Hodgkin lymphoma,"AMBINDER, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$178,438"
Lymphoma,2015,NCI,1R01CA192928-01A1,,Dual targeting of XPO1 and BTK in B cell malignancies,"LAPALOMBELLA, ROSA",OHIO STATE UNIVERSITY,OH,"$319,550"
Lymphoma,2015,NCI,5K08CA151450-06,,Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma,"LABELLE, JAMES",UNIVERSITY OF CHICAGO,IL,"$168,048"
Lymphoma,2015,NCI,5F30CA177173-03,,Role of Shcbp1 (mPAL) in T Cell Development and Function,"BUCKLEY, MONICA",UNIVERSITY OF VIRGINIA,VA,"$48,120"
Lymphoma,2015,NCI,5P01CA095426-14,5850,Innate Immune Therapy for B-Cell Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$381,967"
Lymphoma,2015,NCI,5P01CA095426-14,5857,MOUSE MODELING AND ANIMAL DEVELOPMENT,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$247,366"
Lymphoma,2015,NIAID,7R21AI116205-02,,"Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin","HENRICH, TIMOTHY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$205,651"
Lymphoma,2015,NCI,5F31CA180451-03,,Temporal regulation of the essential Epstein-Barr virus oncoprotein LMP1,"PRICE, ALEXANDER",DUKE UNIVERSITY,NC,"$33,389"
Lymphoma,2015,NCI,5R01CA164311-05,,MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm,"EVENS, ANDREW",TUFTS MEDICAL CENTER,MA,"$345,726"
Lymphoma,2015,NCI,5P01CA044991-27,8453,Radioimmunotherapy for Lymphoma,"GOPAL, AJAY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$269,552"
Lymphoma,2015,NCI,5P01CA044991-27,8454,Pretargeted Radioimmunotherapy for Hematologic Malignancies,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$317,115"
Lymphoma,2015,NCI,5P01CA044991-27,8455,Administrative and Statistical Core,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$450,309"
Lymphoma,2015,NCI,5P01CA044991-27,8456,Nuclear Medicine Core,"RAJENDRAN, JOSEPH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$623,183"
Lymphoma,2015,NCI,5P01CA044991-27,8457,Biologics Production Core,"BALDWIN, JANELL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$267,090"
Lymphoma,2015,NCI,5R01CA103646-09,,Modeling KSHV latency in vivo,"CESARMAN, ETHEL",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$328,499"
Lymphoma,2015,NHLBI,1R21HL125018-01A1,,Bispecific cytotoxic lymphocytes in HIV-related lymphoma,"LIU, DONGFANG",BAYLOR COLLEGE OF MEDICINE,TX,"$242,204"
Lymphoma,2015,NCI,5P01CA165997-03,8409,Micro-RNA-dependent regulation of the UPR,"DIEHL, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$310,159"
Lymphoma,2015,NCI,5P01CA165997-03,8411,Role of the UPR in myc-induced tumorigenesis,"KOUMENIS, CONSTANTINOS",UNIVERSITY OF PENNSYLVANIA,PA,"$263,224"
Lymphoma,2015,NCI,5P01CA165997-03,8412,"UPR, interferon signaling and tumorigenesis","FUCHS, SERGE",UNIVERSITY OF PENNSYLVANIA,PA,"$305,838"
Lymphoma,2015,NIDCR,5DP5OD012160-05,,Detection of Chromosomal Translocations by Single Molecule RNA Imaging,"BATISH, MONA",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,$1
Lymphoma,2015,RMAP,5DP5OD012160-05,,Detection of Chromosomal Translocations by Single Molecule RNA Imaging,"BATISH, MONA",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,"$459,980"
Lymphoma,2015,NCI,5R01CA093237-14,,Nuclear Accumulation of Cyclin D1 and Oncogenesis,"DIEHL, JOHN",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$278,127"
Lymphoma,2015,NCI,5K99CA175181-02,,The role of viral and cellular miRNAs in B-cell lymphomagenesis,"SKALSKY, REBECCA",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$99,351"
Lymphoma,2015,NCI,5R21CA179302-02,,Characterization of a non-canonical role for Foxo1 in B cell lymphoma,"RICKERT, ROBERT",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$212,063"
Lymphoma,2015,NCI,5P50CA126752-09,0001,T CELL THERAPY TARGETING MULTIPLE TUMOR ANTIGENS IN HODGKIN LYMPHOMA,"LEEN, ANN",BAYLOR COLLEGE OF MEDICINE,TX,"$235,961"
Lymphoma,2015,NCI,5P50CA126752-09,0002,CHIMERIC T CELL ANTIGENS TARGETING IG KAPPA LIGHT CHAIN IN B CELL LYMPHOMA,"DOTTI, GIANPIETRO",BAYLOR COLLEGE OF MEDICINE,TX,"$222,662"
Lymphoma,2015,NCI,5P50CA126752-09,0003,BUILDING ON SUCCESSFUL T CELL THERAPY FOR EBV LYMPHOMA,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$217,047"
Lymphoma,2015,NCI,5P50CA126752-09,0004,TARGETING CHEMORESISTANT TUMOR-INITIATING CELLS IN CLL,"FOSTER, AARON",BAYLOR COLLEGE OF MEDICINE,TX,"$220,891"
Lymphoma,2015,NCI,5P50CA126752-09,0006,ADMINISTRATIVE CORE,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$142,142"
Lymphoma,2015,NCI,5P50CA126752-09,9001,Clinical Research Core,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$145,501"
Lymphoma,2015,NCI,5P50CA126752-09,9002,Biostatistics,"LIU, HAO",BAYLOR COLLEGE OF MEDICINE,TX,"$137,428"
Lymphoma,2015,NCI,5P50CA126752-09,9003,Cell and Vector Production,"GEE, ADRIAN",BAYLOR COLLEGE OF MEDICINE,TX,"$265,039"
Lymphoma,2015,NCI,5P50CA126752-09,9004,BIOSPECIMEN AND PATHOLOGY CORE,"SHEEHAN, ANDREA",BAYLOR COLLEGE OF MEDICINE,TX,"$283,394"
Lymphoma,2015,NCI,5P50CA126752-09,7045,DEVELOPMENTAL RESEARCH PROGRAM,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$157,467"
Lymphoma,2015,NCI,5P50CA126752-09,7046,CAREER DEVELOPMENT PROGRAM,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$157,467"
Lymphoma,2015,NCI,5R03CA188614-02,,Risk of hematologic cancers from repeated low-dose diagnostic radiation,"ZABLOTSKA, LYDIA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$79,250"
Lymphoma,2015,NIGMS,5R01GM112192-02,,Enhancer Driven Gene Regulation During Lymphocyte Development,"SKOK, JANE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$525,166"
Lymphoma,2015,NIDCR,1R01DE024971-01A1,,Platform technology for detection of cancer-associated viruses in HIV patients,"DEMIRCI, UTKAN",STANFORD UNIVERSITY,CA,"$424,398"
Lymphoma,2015,NIAID,1R21AI118509-01,,TRIM protein-mediated innate immune control of KSHV infection,"GACK, MICHAELA",HARVARD MEDICAL SCHOOL,MA,"$207,026"
Lymphoma,2015,NCI,5R01CA188005-02,,Therapeutic In Situ Vaccination for Human Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$311,682"
Lymphoma,2015,NCI,1R13CA196357-01,,18th International Workshop on Kaposi's sarcoma herpesvirus and related agents,"MESRI, ENRIQUE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$9,000"
Lymphoma,2015,NCI,5R01CA182736-03,,MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL,"GRAY, NATHANAEL",DANA-FARBER CANCER INST,MA,"$708,042"
Lymphoma,2015,NCI,5P01CA015396-40,5878,Targeting Cancer Stem Cells,"JONES, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$343,404"
Lymphoma,2015,NCI,5R01CA136895-07,,Understanding the context-dependent roles of mutations in lymphoma.,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$286,200"
Lymphoma,2015,NCI,2R01CA075922-19A1,,Rhesus HHV-8 homologue in AIDS-related malignancies,"WONG, SCOTT",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$666,638"
Lymphoma,2015,NIAID,1R21AI118606-01,,Isolation of Regulators of Immune Cell Behavior,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$243,000"
Lymphoma,2015,NCI,7R01CA154739-04,,Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics,"CLEVELAND, JOHN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$630,698"
Lymphoma,2015,NCI,2P30CA091842-14,6313,Hematopoietic Development and Malignancy (Project-002),"EBERLEIN, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$60,323"
Lymphoma,2015,NCI,1R33CA191159-01A1,,Using Adductomics to Characterize Exposures to Carcinogens,"RAPPAPORT, STEPHEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$380,395"
Lymphoma,2015,NIAID,5R01AI045073-17,,Chemokines and Lymphoid Tissue Organization and Function,"CYSTER, JASON","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$356,625"
Lymphoma,2015,NCI,5R42CA183708-04,,An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re,"PARSONS, CHRISTOPHER",APOGEE BIOTECHNOLOGY CORPORATION,PA,"$499,411"
Lymphoma,2015,NCI,5R01CA136551-07,,Targeted therapy of B cell malignances with CAR-T cells of defined composition,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$560,424"
Lymphoma,2015,FIC,5U54CA190146-02,6249,Project 2,"CASPER, COREY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$6,525"
Lymphoma,2015,NCI,5U54CA190146-02,6249,Project 2,"CASPER, COREY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$101,876"
Lymphoma,2015,NCI,5K99CA190861-02,,Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies,"OTT, CHRISTOPHER",DANA-FARBER CANCER INST,MA,"$98,107"
Lymphoma,2015,NCI,5R44CA159843-03,,A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma,"BALHORN, RODNEY","SHAL TECHNOLOGIES, INC.",CA,"$740,587"
Lymphoma,2015,NCI,5R00CA157954-04,,Convergence of CREB and MYC Pathways in Oncogenesis.,"AMELIO, ANTONIO",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$249,000"
Lymphoma,2015,NCI,5P01CA081534-15,6644,Molecular Genetics,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$533,439"
Lymphoma,2015,NCI,5P01CA081534-15,6645,Molecular Inhibition of Apoptosis Inhibitors,"REED, JOHN",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$453,812"
Lymphoma,2015,NCI,5P01CA081534-15,6646,Immune Therapy,"KIPPS, THOMAS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$241,511"
Lymphoma,2015,NCI,5P01CA081534-15,6647,Immune Tolerance and Stem Cell Transplantation,"GRIBBEN, JOHN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$242,290"
Lymphoma,2015,NCI,5P01CA081534-15,6648,Mechanism-Based Pharmacologic Intervention,"PLUNKETT, WILLIAM",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$144,879"
Lymphoma,2015,NCI,5P01CA081534-15,6649,Pharmacologic Inhibitors of Cellular Kinases and Signal Transduction,"GREVER, MICHAEL",OHIO STATE UNIVERSITY,OH,"$224,967"
Lymphoma,2015,NCI,5P01CA081534-15,6650,Administrative and Informatics,"KIPPS, THOMAS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$610,335"
Lymphoma,2015,NCI,5P01CA081534-15,6651,Biostatistics,"NEUBERG, DONNA",DANA-FARBER CANCER INST,MA,"$175,094"
Lymphoma,2015,NCI,5P01CA081534-15,6652,Tissue Core,"RASSENTI, LAURA",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$544,088"
Lymphoma,2015,NCI,5P01CA081534-15,6653,Clinical Program,"WIERDA, WILLIAM",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$637,192"
Lymphoma,2015,NCI,5P01CA148600-05,5304,CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies,"DOTTI, GIANPIETRO",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$395,087"
Lymphoma,2015,NCI,5P01CA148600-05,5309,Molecular Imaging Core,"GELOVANI, JURI",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$204,530"
Lymphoma,2015,NCI,2P01CA016038-41A1,7371,"Project 1, Miller: Novel Functions of the Epstein-Barr Viral Lytic Cycle Activator Protein ZEBRA","MILLER, I.",YALE UNIVERSITY,CT,"$197,955"
Lymphoma,2015,NCI,5P01CA078902-17,5395,Project 3: Stem Cell Allografts for Lymphoid Malignancies,"MALONEY, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$257,616"
Lymphoma,2015,NCI,5P01CA078902-17,7384,Program Integration and management,"STORB, RAINER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$18,647"
Lymphoma,2015,FIC,5U54CA190152-02,7397,Project 2,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$16,440"
Lymphoma,2015,NCI,5U54CA190152-02,7397,Project 2,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$230,128"
Lymphoma,2015,FIC,5U54CA190152-02,7398,Project 3,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$10,315"
Lymphoma,2015,NCI,5U54CA190152-02,7398,Project 3,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$144,386"
Lymphoma,2015,NCI,5F31CA186237-02,,Development of a Coiled-Coil therapeutic for Non-Hodgkin's Lymphoma,"HARTLEY, JONATHAN",UNIVERSITY OF UTAH,UT,"$33,319"
Lymphoma,2015,NCI,5P30CA013696-41,6105,Lymphoid Development and Malignancy Program,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$35,133"
Lymphoma,2015,NCI,5P30CA013696-41,6127,Recruitment,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$95,447"
Lymphoma,2015,NCI,5P30CA023100-29,6336,Hematologic Malignancies,"LIPPMAN, SCOTT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$20,990"
Lymphoma,2015,NCI,5R44CA168019-03,,Automated Ultrasensitive Detection of Light Chain Restriction in Lymphoproliferat,"MA, XIAO-JUN","ADVANCED CELL DIAGNOSTICS, INC.",CA,"$529,530"
Lymphoma,2015,NCI,5R42CA173900-03,,Targeting B-cell lymphoma with Leukothera-phase II,"BELINKA, BENJAMIN","ACTINOBAC BIOMED, INC.",NJ,"$894,222"
Lymphoma,2015,RMAP,5K01ES025431-02,,The role of epigenetic heterogeneity in CLL evolution,"LANDAU, DAN",DANA-FARBER CANCER INST,MA,"$187,424"
Lymphoma,2015,NCI,5P01CA094237-13,7520,VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$295,515"
Lymphoma,2015,NCI,5P01CA094237-13,7522,ENGINEERING T CELLS FOR PANCREATIC CANCER,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$254,484"
Lymphoma,2015,NCI,5P01CA100730-12,5163,Core C: Animal Models,"NIEWIESK, STEFAN",OHIO STATE UNIVERSITY,OH,"$304,455"
Lymphoma,2015,NCI,5P01CA100730-12,5166,Project 3: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment in ATL,"WEILBAECHER, KATHERINE",OHIO STATE UNIVERSITY,OH,"$312,014"
Lymphoma,2015,NCI,5P01CA100730-12,5167,Project 4: Tumorigenic Effects of Tax,"RATNER, LEE",OHIO STATE UNIVERSITY,OH,"$433,132"
Lymphoma,2015,NCI,1R01CA196703-01,,Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma,"CHIARLE, ROBERTO",CHILDREN'S HOSPITAL CORPORATION,MA,"$404,316"
Lymphoma,2015,NCI,1R01CA197120-01,,Predicting clinical outcome in individuals with small CLL B cell clones,"SHANAFELT, TAIT",MAYO CLINIC ROCHESTER,MN,"$615,766"
Lymphoma,2015,NCI,1R01CA197870-01,,Improving BTK Directed Therapy for CLL,"WOYACH, JENNIFER",OHIO STATE UNIVERSITY,OH,"$352,275"
Lymphoma,2015,NCI,1R01CA197844-01,,Phosphatase activation as therapeutic strategy for Chronic lymphocyic leukemia,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$437,656"
Lymphoma,2015,NCI,1R01CA197801-01,,Identification of Loci Modifying Atm Lymphomagenesis,"WEIL, MICHAEL",COLORADO STATE UNIVERSITY,CO,"$351,973"
Lymphoma,2015,NCI,1R01CA197945-01,,The role of RHOA G17V mutation in peripheral t-cell lymphomas,"PALOMERO, TERESA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Lymphoma,2015,NCI,1K08CA197367-01,,The role of Galpha13 signaling in development and dissemination of lymphoma,"MUPPIDI, JAGAN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$175,495"
Lymphoma,2015,NCI,1R21CA198072-01,,Passenger mutations due to activation-induced deaminase as biomarkers in lymphoma,"BURACK, WALTER",UNIVERSITY OF ROCHESTER,NY,"$214,206"
Lymphoma,2015,NIAID,1R21AI119480-01,,Structure and function of EBV protein complexes that trigger epithelial cell entry,"JARDETZKY, THEODORE",STANFORD UNIVERSITY,CA,"$264,750"
Lymphoma,2015,NCI,1R35CA197734-01,,Targeted Therapy for Leukemia,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$911,328"
Lymphoma,2015,NCI,1R35CA197706-01,,Cancer Gene Discovery to Identify Targetable Targets,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$924,000"
Lymphoma,2015,NCI,1R21CA184469-01A1,,Generation of NKT cells from adult stem cells for adoptive immunotherapy,"WEBB, TONYA",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$200,318"
Lymphoma,2015,NCI,1R03CA188619-01A1,,THE ROLE OF MALT1 IN MELANOMA GROWTH AND METASTASIS,"ZHANG, YUNYAN JENNIFER",DUKE UNIVERSITY,NC,"$79,500"
Lymphoma,2015,NCI,3R01CA113809-09S1,,Role of Missing Metastasis Gene in Tumor Progression,"ZHAN, STEVEN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$57,179"
Lymphoma,2015,NCI,1R21CA198561-01,,SYNERGIZING PRO-APOPTOTIC AND CAR-T CELL IMMUNOTHERAPY FOR MANTLE CELL LYMPHOMA,"KATZ, SAMUEL",YALE UNIVERSITY,CT,"$217,283"
Lymphoma,2015,NCI,1R21CA185875-01A1,,Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM,"SMITH, EILEEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$207,513"
Lymphoma,2015,NIAID,1R21AI119894-01,,Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis,"KEE, BARBARA",UNIVERSITY OF CHICAGO,IL,"$191,932"
Lymphoma,2015,NIGMS,2R01GM095606-05,,Drug-Free Macromolecular Therapeutics,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$298,000"
Lymphoma,2015,NCI,1R01CA190628-01A1,,Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing,"FANG, BINGLIANG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$511,434"
Lymphoma,2015,NCI,1R01CA187799-01A1,,Role of FOXP1 and WNT signaling in B-cell Lymphoma,"MAJOR, MICHAEL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$307,500"
Lymphoma,2015,NCI,2R01CA095318-11A1,,Role of B cells in murine gammaherpesvirus 68,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$368,305"
Lymphoma,2015,NCI,1R01CA190860-01A1,,Pharmacological Blockage of XBP-1s Expression in Cancer,"DEL VALLE, JUAN",UNIVERSITY OF SOUTH FLORIDA,FL,"$468,524"
Lymphoma,2015,NIAID,2R01AI041649-15,,Determinants of germinal center B cell differentiation,"RICKERT, ROBERT",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$487,500"
Lymphoma,2015,NCI,1K08CA191019-01A1,,The role of ZEB1 mutations in cutaneous T cell lymphoma,"CHOI, JAEHYUK",YALE UNIVERSITY,CT,"$152,796"
Lymphoma,2015,NCI,1R21CA191380-01A1,,Role of lncRNAs in Clinical Heterogeneity of Early Stage IGHV Unmutated CLL,"JELINEK, DIANE",MAYO CLINIC ROCHESTER,MN,"$207,495"
Lymphoma,2015,NCI,1R03CA199515-01,,Occupational Pesticide Use and Risk of Lymphoid Cancers,"DE ROOS, ANNECLAIRE",DREXEL UNIVERSITY,PA,"$78,250"
Lymphoma,2015,NCI,1R21CA199544-01,,NKT cells with chimeric antigen receptors,"WEBB, TONYA",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$166,931"
Lymphoma,2015,NCI,1R21CA199553-01,,Optimization and Efficacy of Covalent Ire-1 RNase Inhibitors in CLL,"DEL VALLE, JUAN",UNIVERSITY OF SOUTH FLORIDA,FL,"$187,475"
Lymphoma,2015,NCI,3UM1CA173642-03S1,,Obesity and mortality after breast cancer diagnosis by race/ethnicity in the WHI Clinical Trial and Observational Cohorts,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$113,842"
Lymphoma,2015,NCI,3R01CA168482-03S1,,HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$172,226"
Lymphoma,2015,NIAID,1R41AI115834-01A1,,sxRNA-based Antiviral Approach targeting Epstein-Barr virus,"BHADURI-MCINTOSH, SUMITA","HOCUSLOCUS, LLC",NY,"$225,000"
Lymphoma,2015,RMAP,3R01CA166450-03S1,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$385,000"
Lymphoma,2015,NCI,2UM1CA121947-09,,AIDS Malignancy Consortium (AMC),"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$13,134,493"
Lymphoma,2015,NCI,1R21CA189703-01A1,,Clinicopathological significance of PDLIM2 in HIV/AIDS-related malignancies caused by KSHV,"QU, ZHAOXIA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$167,475"
Lymphoma,2015,NCI,1R21CA196348-01A1,,HHV-8 vIRF interactions in the context of infection,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$176,175"
Lymphoma,2015,NCI,261200800001E-77-0-35,,Genotyping for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$8,145,205"
Lymphoma,2015,NCI,261200800001E-77-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$2,282,355"
Lymphoma,2015,NCI,261200800001E-77-0-51,,DCTD Biopharmaceutical Development,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$6,373,511"
Lymphoma,2015,NCI,261200800001E-77-0-105,,OCG Web Transition and Development,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$19,083"
Lymphoma,2015,NCI,1K24CA201524-01,,Development of a comprehensive research program in mantle cell lymphoma in the ibrutinib era,"BLUM, KRISTIE",OHIO STATE UNIVERSITY,OH,"$179,754"
Lymphoma,2015,NCI,3R01CA166450-03S2,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$51,493"
Lymphoma,2015,NCI,3P30CA124435-08S3,,Stanford University Cancer Center,"MITCHELL, BEVERLY",STANFORD UNIVERSITY,CA,"$2,249,153"
Lymphoma,2015,NCI,3P30CA023074-35S5,,Arizona Cancer Center-Cancer Center Support Grant,"KRAFT, ANDREW",UNIVERSITY OF ARIZONA,AZ,"$1,917,600"
Lymphoma,2015,NCI,3R01CA154674-05S1,,Cotranslational Functions of MTOR,"JACINTO, ESTELA",RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,NJ,"$65,636"
Lymphoma,2015,NIGMS,1R01GM105821-01A1,,SAP/NTB-A Signaling in T Cell Restimulation-Induced Cell Death,"SNOW, ANDREW",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$311,513"
Lymphoma,2015,NCI,3R01CA076167-12S1,,Genetic Analysis of Myeloproliferative Disease,"COWELL, JOHN",GEORGIA REGENTS UNIVERSITY,GA,"$82,142"
Lymphoma,2015,NCI,3R01CA155010-05S1,,Personal tumor neoantigens for immunity against chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$432,500"
Lymphoma,2015,NCI,3R01CA158323-04S1,,Studies of Lymphoma Suppression and DNA Repair,"DU, CHUNYING",UNIVERSITY OF CINCINNATI,OH,"$36,508"
Lymphoma,2015,NCI,1R44CA195812-01A1,,Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma,"WONG, HING",ALTOR BIOSCIENCE CORPORATION,FL,"$961,768"
Lymphoma,2015,NCI,1U13ES026496-01,,Childhood Leukemia International Consortium Scientific Annual Meetings,"METAYER, CATHERINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$2,000"
Lymphoma,2015,NIEHS,1U13ES026496-01,,Childhood Leukemia International Consortium Scientific Annual Meetings,"METAYER, CATHERINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$12,000"
Lymphoma,2015,NCI,7K08CA158069-05,,The Role of Heme Metabolic Pathways in T Cell Development and T Cell Lymphomagene,"PHILIP, MARY",SLOAN-KETTERING INST CAN RESEARCH,NY,"$167,400"
Lymphoma,2015,NIEHS,3R01ES021832-03S1,,Endocrine disrupter modulation of SXR in development and lymphomagenesis,"BLUMBERG, BRUCE",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$58,007"
Lymphoma,2015,NCI,3P01CA119070-09S1,,Oncogenic Notch Signaling,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$58,609"
Lymphoma,2015,NCI,3R01CA140337-05S1,,Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$66,880"
Lymphoma,2015,NCI,3F30CA177173-02S1,,Role of Shcbp1 (mPAL) in T Cell Development and Function,"BUCKLEY, MONICA",UNIVERSITY OF VIRGINIA,VA,"$7,472"
Lymphoma,2015,NHLBI,7R01HL114564-03,,Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes,"SAVOLDO, BARBARA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$440,384"
Lymphoma,2015,NCI,7R01CA190696-02,,A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose,"SCHATZ, JONATHAN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$312,436"
Lymphoma,2015,NCI,3P30CA023074-35S6,,Arizona Cancer Center-Cancer Center Support Grant,"KRAFT, ANDREW",UNIVERSITY OF ARIZONA,AZ,"$50,000"
Lymphoma,2015,NCI,3P30CA023074-35S7,,Arizona Cancer Center-Cancer Center Support Grant,"KRAFT, ANDREW",UNIVERSITY OF ARIZONA,AZ,"$124,932"
Lymphoma,2015,NIA,1ZIAAG000777-04,,Effect of Age on Antibody Diversity,"GEARHART, PATRICIA",NIH,,"$1,125,975"
Lymphoma,2015,NIDDK,1ZIADK036167-09,,Structural studies of the post-cleavage complex in V(D)J recombination,"GELLERT, MARTIN",NIH,,"$1,300,344"
Lymphoma,2015,NCI,1ZIABC009287-31,,Cytokines and T Cell Development,"DURUM, SCOTT",NIH,,"$661,045"
Lymphoma,2015,NCI,1ZIABC009405-21,,Regulation of Lymphocyte Proliferation and Replicative Capacity,"HODES, RICHARD",NIH,,"$566,996"
Lymphoma,2015,NCI,1ZIABC010008-20,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$406,274"
Lymphoma,2015,NCI,1ZIABC010283-18,,DNA repair,"NUSSENZWEIG, ANDRE",NIH,,"$1,269,365"
Lymphoma,2015,NCI,1ZIABC010301-18,,Development of Recombinant Toxins to Treat Hematologic Malignancies,"KREITMAN, ROBERT",NIH,,"$1,065,252"
Lymphoma,2015,NCI,1ZIABC010304-17,,Biochemical Basis of T Cell Activation,"SAMELSON, LAWRENCE",NIH,,"$1,948,521"
Lymphoma,2015,NCI,1ZIABC010621-12,,Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,"BATES, SUSAN",NIH,,"$1,188,387"
Lymphoma,2015,NCI,1ZIABC010717-10,,Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"WILSON, WYNDHAM",NIH,,"$145,652"
Lymphoma,2015,NCI,1ZIABC010719-10,,Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"WILSON, WYNDHAM",NIH,,"$145,652"
Lymphoma,2015,NCI,1ZIABC010728-10,,Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"WILSON, WYNDHAM",NIH,,"$72,826"
Lymphoma,2015,NCI,1ZIABC010747-10,,Characterization of the Expression and Ligands of KIR3DS1,"MCVICAR, DANIEL",NIH,,"$155,855"
Lymphoma,2015,NCI,1ZIABC010779-09,,Regulation and Consequences of Ubiquitination,"ASHWELL, JONATHAN",NIH,,"$321,498"
Lymphoma,2015,NCI,1ZIABC010885-08,,Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,"YARCHOAN, ROBERT",NIH,,"$941,513"
Lymphoma,2015,NCI,1ZIABC010888-08,,Clinical Trials of Patients with AIDS-Related Malignancies,"YARCHOAN, ROBERT",NIH,,"$1,365,193"
Lymphoma,2015,NCI,1ZIABC010957-08,,Transplant Models,"GRESS, RONALD",NIH,,"$1,271,094"
Lymphoma,2015,NCI,1ZIABC010982-08,,Collaborative Pathways that Lead to Leukemia,"APLAN, PETER",NIH,,"$363,806"
Lymphoma,2015,NCI,1ZIABC011006-08,,Molecular diagnosis and outcome prediction in lymphoma,"STAUDT, LOUIS",NIH,,"$1,283,581"
Lymphoma,2015,NCI,1ZIABC011007-08,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$1,283,581"
Lymphoma,2015,NCI,1ZIABC011008-08,,Oncogenic mechanisms and molecular targets in lymphoma,"STAUDT, LOUIS",NIH,,"$1,283,581"
Lymphoma,2015,NCI,1ZIABC011010-08,,Oncogenic mechanisms and molecular targets in myeloma,"STAUDT, LOUIS",NIH,,"$1,283,581"
Lymphoma,2015,NCI,1ZIABC011065-08,,Preclinical Testing of HDAC and mTOR Inhibitors,"MOCK, BEVERLY",NIH,,"$457,057"
Lymphoma,2015,NCI,1ZIABC011070-08,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$954,859"
Lymphoma,2015,NCI,1ZIABC011219-07,,Combination Gene Therapy and Th1Th2 Therapy,"FOWLER, DANIEL",NIH,,"$367,403"
Lymphoma,2015,NCI,1ZIABC011354-06,,BCR Signaling in ABC DLBCL,"WILSON, WYNDHAM",NIH,,"$145,652"
Lymphoma,2015,NCI,1ZIABC011374-05,,Allotransplant for DOCK8 deficiency,"HICKSTEIN, DENNIS",NIH,,"$566,128"
Lymphoma,2015,NCI,1ZIABC011413-05,,Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$50,565"
Lymphoma,2015,NCI,1ZIABC011415-05,,Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$202,262"
Lymphoma,2015,NCI,1ZIABC011417-05,,New Chimeric Antigen Receptors for Treating Hematologic Malignancies,"KOCHENDERFER, JAMES",NIH,,"$202,262"
Lymphoma,2015,NCI,1ZIABC011471-04,,Cell-free assay technologies for the identification of active compounds,"OKEEFE, BARRY",NIH,,"$872,042"
Lymphoma,2015,NCI,1ZIABC011511-03,,Chemical Targeting of Multi-Protein Complexes,"BERNAL, FEDERICO",NIH,,"$366,481"
Lymphoma,2015,NCI,1ZIABC011654-01,,TEDDI-R in PCNSL,"WILSON, WYNDHAM",NIH,,"$218,477"
Lymphoma,2015,NCI,1ZIABC011660-01,,Development of fully-human anti-CD30 chimeric antigen receptors,"KOCHENDERFER, JAMES",NIH,,"$303,392"
Lymphoma,2015,NCI,1ZIACP004410-39,,Family Studies,"TUCKER, MARGARET",NIH,,"$3,831,141"
Lymphoma,2015,NCI,1ZIACP005782-21,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$416,845"
Lymphoma,2015,NCI,1ZIACP005803-21,,Genetic Epidemiology,"GOLDSTEIN, ALISA",NIH,,"$909,165"
Lymphoma,2015,NCI,1ZIACP010125-20,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,393,963"
Lymphoma,2015,NCI,1ZIACP010131-20,,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"BERRINGTON, AMY",NIH,,"$3,052,779"
Lymphoma,2015,NCI,1ZIACP010150-16,,"Infections, immunity, and inflammation in cancer","ENGELS, ERIC",NIH,,"$1,085,068"
Lymphoma,2015,NCI,1ZIACP010170-15,,Multidisciplinary Studies of Hematopoietic Malignancies,"MORTON, LINDSAY",NIH,,"$569,965"
Lymphoma,2015,NCI,1ZIACP010176-15,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$3,239,380"
Lymphoma,2015,NCI,1ZIACP010181-13,,Methods for Epidemiology Studies,"CHATTERJEE, NILANJAN",NIH,,"$3,219,073"
Lymphoma,2015,NCI,1ZIACP010183-13,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$168,914"
Lymphoma,2015,NCI,1ZIACP010184-13,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$1,736,219"
Lymphoma,2015,NCI,1ZIACP010212-06,,Molecular mechanisms of infection-related cancer,"RABKIN, CHARLES",NIH,,"$212,784"
Lymphoma,2015,NCI,1ZIASC000550-35,,Lymphoma Disease Discovery and Definition,"JAFFE, ELAINE",NIH,,"$835,502"
Lymphoma,2015,NCI,1ZIASC006741-23,,Lymphoma Studies,"WILSON, WYNDHAM",NIH,,"$728,259"
Lymphoma,2015,NCI,1ZIASC010282-18,,Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),"ARTHUR, DIANE",NIH,,"$107,105"
Lymphoma,2015,NCI,1ZIASC010288-18,,Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,"FOWLER, DANIEL",NIH,,"$734,808"
Lymphoma,2015,NCI,1ZIASC010356-16,,A Role for KSHV in the Pathogenesis of Malignancies,"TOSATO, GIOVANNA",NIH,,"$345,134"
Lymphoma,2015,NCI,1ZIASC010357-16,,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"ZHENG, ZHI-MING",NIH,,"$1,205,878"
Lymphoma,2015,NCI,1ZIASC010378-15,,Activation of Proto-Oncogenes by Chromosomal Translocation,"APLAN, PETER",NIH,,"$727,613"
Lymphoma,2015,NCI,1ZICBC011029-08,,Preclinical development and clinical monitoring of adoptive immune therapy,"HAKIM, FRANCES",NIH,,"$470,080"
Lymphoma,2015,NCI,1ZICBC011079-08,,Molecular Diagnostics Core Laboratory,"RAFFELD, MARK",NIH,,"$635,058"
Lymphoma,2015,NCI,1ZICBC011093-08,,Flow Cytometric Detection of Malignant Cells in Body Fluids,"STETLER-STEVENSON, MARYALICE",NIH,,"$229,049"
Lymphoma,2015,NCI,1ZICBC011623-01,,CCR Genomics Core,"CONNER, ELIZABETH",NIH,,"$702,309"
Lymphoma,2015,NCI,1ZICSC006537-22,,Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,"FIGG, WILLIAM",NIH,,"$479,619"
Lymphoma,2015,NCI,1ZIDBC010963-08,,ETIB Clinical Research Core,"GRESS, RONALD",NIH,,"$1,492,154"
Lymphoma,2015,NCI,1ZIDBC010990-08,,Radiation Oncology Branch - Radiation Clinic,"CAMPHAUSEN, KEVIN",NIH,,"$6,587,182"
Lymphoma,2015,NCI,1ZIDBC011658-01,,LyMB Clinical Trials Team,"WALDMANN, THOMAS",NIH,,"$1,210,652"
Lymphoma,2015,NCI,1ZIEBC010843-09,,Medical Oncology Fellowship Program,"GULLEY, JAMES",NIH,,"$6,114,523"
Lymphoma,2015,NCI,1ZIEBC011241-07,,Hematopathology Fellowship,"JAFFE, ELAINE",NIH,,"$596,786"
Lymphoma,2015,NCI,1ZIGBC010856-09,,Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,"CUSTER, MARY",NIH,,"$20,241,774"
Lymphoma,2015,NEI,1ZIAEY000222-30,,Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases,"CHAN, CHI-CHAO",NIH,,"$514,777"
Lymphoma,2015,NEI,1ZIAEY000356-15,,Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis),"NUSSENBLATT, ROBERT",NIH,,"$540,633"
Lymphoma,2015,NHLBI,1ZIAHL002346-11,,"Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy","WIESTNER, ADRIAN",NIH,,"$1,252,072"
Lymphoma,2015,NHLBI,1ZIAHL005076-10,,"Novel therapies for Mantle Cell Lymphoma: targets, mechanisms, and prognosis","WIESTNER, ADRIAN",NIH,,"$208,679"
Lymphoma,2015,NHLBI,1ZIAHL006070-06,,Immunotherapy of low grade lymphoid malignancies,"WIESTNER, ADRIAN",NIH,,"$626,036"
Lymphoma,2015,NIAID,1ZIAAI000565-19,,Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B,"LENARDO, MICHAEL",NIH,,"$295,084"
Lymphoma,2015,NIAID,1ZIAAI000717-21,,Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models,"LENARDO, MICHAEL",NIH,,"$737,711"
Lymphoma,2015,NIAID,1ZIAAI000732-21,,"Clinical, Immunological and Genetic  Analyses of ALPS","RAO, VEMULKONDA",NIH,,"$505,345"
Lymphoma,2015,NIAID,1ZIAAI000733-21,,Enveloped Virus Glycoprotein/receptor Interactions,"BERGER, EDWARD",NIH,,"$273,034"
Lymphoma,2015,NIAID,1ZIAAI000769-19,,Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome,"LENARDO, MICHAEL",NIH,,"$737,711"
Lymphoma,2015,NIAID,1ZIAAI000858-16,,Lymphomas And Retroviral Pathogenesis,"MORSE, HERBERT",NIH,,"$560,467"
Lymphoma,2015,NIAID,1ZIAAI000913-14,,Epstein-Barr Virus Associated Disorders,"COHEN, JEFFREY",NIH,,"$958,430"
Lymphoma,2015,NIAID,1ZIAAI000978-10,,Herpesvirus Pathogenesis and Vaccine Development,"COHEN, JEFFREY",NIH,,"$2,643,536"
Lymphoma,2015,NIAID,1ZIAAI001024-09,,Molecular Regulation of B-Cell Differentiation and Function,"MORSE, HERBERT",NIH,,"$747,289"
Lymphoma,2015,NIAID,1ZIAAI001126-06,,B cell Receptor Dysregulation in Cancer and Autoimmune Disease,"PIERCE, SUSAN",NIH,,"$633,317"
Lymphoma,2015,NIAID,1ZIAAI001187-03,,New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior,"LENARDO, MICHAEL",NIH,,"$295,084"
Lymphoma,2015,NCATS,NRC15004001-1-0-1,,funding for FY 15/16 Bench-to-Bedside project “CAR-modified CD8+ memory stem cells targeting B-cell malignancies,NO PI IDENTIFIED,NIH,,"$99,987"
Lymphoma,2015,NCI,261200800001E-77-0-142,,OCG Data Coordinating Center,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$285,600"
